Login / Signup

Association between different diabetes medication classes and risk of Parkinson's disease in people with diabetes.

Katriina SunnarborgMiia TiihonenMarjo HuovinenMarjaana KoponenSirpa HartikainenAnna-Maija Tolppanen
Published in: Pharmacoepidemiology and drug safety (2022)
Our nationwide case-control study of people with diabetes found no robust evidence on the association between specific diabetes medication classes and risk of PD. Consistent with earlier studies, TZD use was associated with slightly decreased risk of PD. The mechanism for this should be verified in further studies.
Keyphrases
  • type diabetes
  • cardiovascular disease
  • glycemic control
  • healthcare
  • metabolic syndrome
  • case control
  • cross sectional